Proposed Data Collections Submitted for Public Comment and Recommendations, 38936-38937 [05-13244]
Download as PDF
<![CDATA[
38936
Federal Register / Vol. 70, No. 128 / Wednesday, July 6, 2005 / Notices
activities to further the health of all
members of their community. Health
care providers can encourage their
patients to pursue healthier lifestyles
and to participate in community-based
programs. By selecting from among the
national objectives, individuals and
organizations can build an agenda for
community health improvement and
can monitor results over time. More
information on the Healthy People 2010
objectives may be found on the Healthy
People 2010 Web site: https://
www.health.gov/healthypeople.
Sustainability: An organization’s or
program’s staying power: the capacity to
maintain both the financial resources
and the partnerships/linkages needed to
provide the services.
Steps to HealthierUS: An initiative of
the U. S. Department of Health and
Human Services that advances the
President’s HealthierUS goal for helping
Americans live longer, better, and
healthier lives. The cornerstones of this
program are physical fitness,
prevention, nutrition, and making
healthy choices. More can be found on
the Web site: https://
www.healthierus.gov.
Health Literacy: Degree to which
individuals have the capacity to obtain,
process and understand basic health
information and services needed to
make appropriate health decisions. In
addition to the IOM report, information
on health literacy can be found at:
https://odphp.osophs.dhhs.gov/projects/
healthcomm/objective2.htm.
Dated: June 23, 2005.
Dalton G. Paxman,
Regional Health Administrator, Region III,
Philadelphia, PA.
[FR Doc. 05–13190 Filed 7–5–05; 8:45 am]
BILLING CODE 4150–33–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Joint Meeting of the National Vaccine
Advisory Committee and the Advisory
Committee on Immunization Practices
Department of Health and
Human Services, Office of the Secretary.
ACTION: Notice.
AGENCY:
SUMMARY: As stipulated by the Federal
Advisory Committee Act, the
Department of Health and Human
Services (DHHS) is hereby giving notice
that the National Vaccine Advisory
Committee (NVAC) and the Advisory
Committee on Immunization Practices
(ACIP) will hold a joint meeting. The
meeting is open to the public.
DATES: The meeting will be held on July
19, 2005, from 9 a.m. to 4:30 p.m.
VerDate jul<14>2003
16:35 Jul 05, 2005
Jkt 205001
Department of Health and
Human Services, 5635 Fishers Lane,
Terrace Level Conference Room,
Rockville, Maryland 20852.
FOR FURTHER INFORMATION CONTACT: Ms.
Emma English, Program Analyst,
National Vaccine Program Office,
Department of Health and Human
Services, Room 443–H, Hubert H.
Humphrey Building, 200 Independence
Avenue, SW., Washington, DC 20201;
telephone (202) 690–5566, or email
nvac@osophs.dhhs.gov.
SUPPLEMENTARY INFORMATION: Pursuant
to Section 2101 of the Public Health
Service Act (42 U.S.C. Section 300aa–1),
the Secretary of Health and Human
services was mandated to establish the
National Vaccine Program to achieve
optimal prevention of human infectious
diseases through immunization and to
achieve optimal prevention against
adverse reactions to vaccines. The
NVAC was established to provide
advice and make recommendations to
the Assistant Secretary for Health, as the
Director of the National Vaccine
Program, on matters related to the
program’s responsibilities.
The ACIP is charged with advising the
Director, Centers for Disease Control
and Prevention (CDC), on the
appropriate uses of immunizing agents.
In addition, under 42 U.S.C. Section
1396s, the ACIP is mandated to
establish and periodically review and,
as appropriate, revise the list of vaccines
for administration to vaccine-eligible
children through the Vaccines for
Children (VFC) program, along with
schedules regarding the appropriate
periodicity, dosage, and
contraindications applicable to the
vaccines.
This is a special meeting of the NVAC
and the ACIP. Discussions will
surround the Department’s draft
Pandemic Influenza Preparedness and
Response Plan. A tentative agenda will
be made available on or about July 5,
2005 for review on the NVAC Web site:
https://www.hhs.gov/nvpo/nvac.
Public attendance at the meeting is
limited to space available. Individuals
must provide a photo ID for entry into
the building. Individuals who plan to
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
notify the designated contact person.
Members of the public will have the
opportunity to provide comments at the
meeting. Public comment will be
limited to five minutes per speaker. Any
members of the public who wish to have
printed material distributed to NVAC
and ACIP members should submit
materials to the Executive Secretary,
ADDRESSES:
PO 00000
Frm 00075
Fmt 4703
Sfmt 4703
NVAC, through the contact person listed
above prior to close of business July 15,
2005. Preregistration is required for both
public attendance and comment. Any
individual who wishes to attend the
meeting and/or participate in the public
comment session should email
nvac@osophs.dhhs.gov or call 202–690–
5566.
For this special meeting, remote
participation will be made available via
a toll-free call-in phone number. This
call-in number can be obtained from the
contact person identified above and will
be operator assisted to provide members
of the public the opportunity to provide
comments to the Committees.
Additionally, this meeting will be Web
cast at https://www.videocast.nih.gov.
Online participants will be able to email comments to the Committees.
However, Committee members may not
have the opportunity to read all written
statements submitted on the day of the
meeting and prior to any votes that may
be taken by the Committees. It is
recommended that written statements
be provided to the Executive Secretary,
NVAC, through the contact person listed
above prior to close of business July 15,
2005.
Dated: June 29, 2005.
Bruce Gellin,
Director, National Vaccine Program Office.
[FR Doc. 05–13226 Filed 7–5–05; 8:45 am]
BILLING CODE 4150–44–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–05–05CG]
Proposed Data Collections Submitted
for Public Comment and
Recommendations
In compliance with the requirement
of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for
opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
Prevention (CDC) will publish periodic
summaries of proposed projects. To
request more information on the
proposed projects or to obtain a copy of
the data collection plans and
instruments, call 404–371–5983 and
send comments to Seleda Perryman,
CDC Assistant Reports Clearance
Officer, 1600 Clifton Road, MS–D74,
Atlanta, GA 30333 or send an e-mail to
omb@cdc.gov.
Comments are invited on: (a) Whether
the proposed collection of information
E:\FR\FM\06JYN1.SGM
06JYN1
38937
Federal Register / Vol. 70, No. 128 / Wednesday, July 6, 2005 / Notices
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Written comments should
be received within 60 days of this
notice.
Proposed Project
Morbidity Monitoring Project
(MMP)—New—National Center for HIV,
STD and TB Prevention (NCHSTP),
Centers for Disease Control and
Prevention (CDC).
Background and Brief Description:
This proposed data collection
supplements the HIV/AIDS surveillance
programs in 26 selected state and local
health departments, which collect
information on persons diagnosed with,
living with, and dying from HIV
infection and AIDS and will incorporate
data elements from two data collections:
regimens. Collection of data from
patient medical records will provide
information on: demographics and
insurance status; the prevalence and
incidence of AIDS-defining
opportunistic illnesses and comorbidities related to HIV disease; the
receipt of prophylactic and
antiretroviral medications; and whether
patients are receiving screening and
treatment according to Public Health
Service guidelines. No other Federal
agency collects national populationbased behavioral and clinical
information from HIV-infected adults in
care. The data will have significant
implications for policy, program
development, and resource allocation at
the state/local and national levels.
CDC is requesting approval for a 3year clearance for data collection. Data
will be collected by 26 Reporting Areas
(19 states, Puerto Rico and 6 separately
funded cities). CDC estimates an average
of 400 respondents per site, resulting in
10,400 respondents for the interview
portion. There will be 2 medical record
abstractors per site, resulting in 52
respondents for the medical record
abstraction. Participation of respondents
is voluntary and there is no cost to the
respondents other than their time.
Supplement to HIV/AIDS Surveillance
(SHAS) project (0920–0262) and the
Adult/Adolescent Spectrum of HIV
Disease (ASD). Both projects stopped
data collection in 2004.
Although CDC receives surveillance
data from all U.S. states, these
supplemental surveillance data are
needed to make estimates of key
indicators, such as quality of HIVrelated ambulatory care and the severity
of need for HIV-related care and
services. A large number of cities and
states are heavily impacted by the HIV/
AIDS epidemic, resulting in the need for
population-based national estimates of
HIV-related behaviors, clinical
outcomes, and quality of HIV care.
This project will collect data on
behaviors and clinical outcomes from a
probability sample of HIV-infected
adults receiving care in the U.S.
Collection of data from interviews with
HIV-infected patients will provide
information on patient demographics,
and the current levels of behaviors that
may facilitate HIV transmission: sexual
and drug use behaviors; patients’ access
to, use of and barriers to HIV-related
secondary prevention services;
utilization of HIV-related medical
services; and adherence to drug
ESTIMATE OF ANNUALIZED BURDEN TABLE
Number of
sites
Type of data collection
Average number of respondents/site
Number of
respondents
Number of
responses per
respondent
Average
burden per
response
(in hours)
Total burden
(in hours)
Persons interviewed .................................
Medical record abstractors ......................
26
26
400
2
10,400
52
1
200
45/60
1
7,800
10,400
Total ..................................................
........................
........................
........................
........................
........................
18,200
Dated: June 21, 2005.
Joan F. Karr,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
[FR Doc. 05–13244 Filed 7–5–05; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–05–0425X]
Proposed Data Collections Submitted
for Public Comment and
Recommendations
In compliance with the requirement
of section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for
opportunity for public comment on
proposed data collection projects, the
VerDate jul<14>2003
16:35 Jul 05, 2005
Jkt 205001
Centers for Disease Control and
Prevention (CDC) will publish periodic
summaries of proposed projects. To
request more information on the
proposed projects or to obtain a copy of
the data collection plans and
instruments, call 404–371–5983 and
send comments to Seleda Perryman,
CDC Assistant Reports Clearance
Officer, 1600 Clifton Road, MS–D74,
Atlanta, GA 30333 or send an e-mail to
omb@cdc.gov.
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
PO 00000
Frm 00076
Fmt 4703
Sfmt 4703
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Written comments should
be received within 60 days of this
notice.
Proposed Project
The National Centers for Autism and
Developmental Disabilities Research
and Epidemiology (CADDRE) Study—
New—National Center for Birth Defects
and Developmental Disabilities
(NCBDDD), Centers for Disease Control
and Prevention (CDC).
Background and Brief Description
The Children’s Health Act of 2000
mandated CDC to establish autism
surveillance and research programs to
address the number, incidence,
correlates, and causes of autism and
related disabilities. Under the
E:\FR\FM\06JYN1.SGM
06JYN1
]]>Agencies
[Federal Register Volume 70, Number 128 (Wednesday, July 6, 2005)]
[Notices]
[Pages 38936-38937]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-13244]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-05-05CG]
Proposed Data Collections Submitted for Public Comment and
Recommendations
In compliance with the requirement of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for opportunity for public comment on
proposed data collection projects, the Centers for Disease Control and
Prevention (CDC) will publish periodic summaries of proposed projects.
To request more information on the proposed projects or to obtain a
copy of the data collection plans and instruments, call 404-371-5983
and send comments to Seleda Perryman, CDC Assistant Reports Clearance
Officer, 1600 Clifton Road, MS-D74, Atlanta, GA 30333 or send an e-mail
to omb@cdc.gov.
Comments are invited on: (a) Whether the proposed collection of
information
[[Page 38937]]
is necessary for the proper performance of the functions of the agency,
including whether the information shall have practical utility; (b) the
accuracy of the agency's estimate of the burden of the proposed
collection of information; (c) ways to enhance the quality, utility,
and clarity of the information to be collected; and (d) ways to
minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques or other
forms of information technology. Written comments should be received
within 60 days of this notice.
Proposed Project
Morbidity Monitoring Project (MMP)--New--National Center for HIV,
STD and TB Prevention (NCHSTP), Centers for Disease Control and
Prevention (CDC).
Background and Brief Description: This proposed data collection
supplements the HIV/AIDS surveillance programs in 26 selected state and
local health departments, which collect information on persons
diagnosed with, living with, and dying from HIV infection and AIDS and
will incorporate data elements from two data collections: Supplement to
HIV/AIDS Surveillance (SHAS) project (0920-0262) and the Adult/
Adolescent Spectrum of HIV Disease (ASD). Both projects stopped data
collection in 2004.
Although CDC receives surveillance data from all U.S. states, these
supplemental surveillance data are needed to make estimates of key
indicators, such as quality of HIV-related ambulatory care and the
severity of need for HIV-related care and services. A large number of
cities and states are heavily impacted by the HIV/AIDS epidemic,
resulting in the need for population-based national estimates of HIV-
related behaviors, clinical outcomes, and quality of HIV care.
This project will collect data on behaviors and clinical outcomes
from a probability sample of HIV-infected adults receiving care in the
U.S. Collection of data from interviews with HIV-infected patients will
provide information on patient demographics, and the current levels of
behaviors that may facilitate HIV transmission: sexual and drug use
behaviors; patients' access to, use of and barriers to HIV-related
secondary prevention services; utilization of HIV-related medical
services; and adherence to drug regimens. Collection of data from
patient medical records will provide information on: demographics and
insurance status; the prevalence and incidence of AIDS-defining
opportunistic illnesses and co-morbidities related to HIV disease; the
receipt of prophylactic and antiretroviral medications; and whether
patients are receiving screening and treatment according to Public
Health Service guidelines. No other Federal agency collects national
population-based behavioral and clinical information from HIV-infected
adults in care. The data will have significant implications for policy,
program development, and resource allocation at the state/local and
national levels.
CDC is requesting approval for a 3-year clearance for data
collection. Data will be collected by 26 Reporting Areas (19 states,
Puerto Rico and 6 separately funded cities). CDC estimates an average
of 400 respondents per site, resulting in 10,400 respondents for the
interview portion. There will be 2 medical record abstractors per site,
resulting in 52 respondents for the medical record abstraction.
Participation of respondents is voluntary and there is no cost to the
respondents other than their time.
Estimate of Annualized Burden Table
--------------------------------------------------------------------------------------------------------------------------------------------------------
Average
Number of Average number Number of Number of burden per Total burden
Type of data collection sites of respondents/ respondents responses per response (in (in hours)
site respondent hours)
--------------------------------------------------------------------------------------------------------------------------------------------------------
Persons interviewed..................................... 26 400 10,400 1 45/60 7,800
Medical record abstractors.............................. 26 2 52 200 1 10,400
-----------------
Total............................................... .............. .............. .............. .............. .............. 18,200
--------------------------------------------------------------------------------------------------------------------------------------------------------
Dated: June 21, 2005.
Joan F. Karr,
Acting Reports Clearance Officer, Centers for Disease Control and
Prevention.
[FR Doc. 05-13244 Filed 7-5-05; 8:45 am]
BILLING CODE 4163-18-P
